Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27430194 | 1.00 | — | — | |
| SCHEMBL689417 | 0.96 | — | — | |
| SCHEMBL28850341 | 0.90 | NOS1 (0.46) | — | |
| Guanidine SCHEMBL28317239 | 0.87 | NOS1 (0.43) | — | |
| Sulfuric Acid SCHEMBL6049591 | 0.82 | BLM (0.50) | — | |
| Phosphoramidic Acid SCHEMBL2237983 | 0.80 | GGPS1 (0.43) | — | |
| SCHEMBL10772112 | 0.76 | — | — | |
| SCHEMBL10772109 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL6290002 | 0.76 | — | — | |
| Methacrylic Acid SCHEMBL29053612 | 0.74 | TDP1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015834-A | Carbon dioxide separation membrane and preparation method thereof | 国家能源投资集团有限责任公司 | 2024-11-26 | — | — | CN | claimed |
| CN-105646467-B | A kind of anticancer compound Aomei replaces Buddhist nun and its synthetic method | 黄燕鸽 | 2018-07-20 | — | — | CN | claimed |
| CN-106380598-A | Synthesis method and application of high-polymer ionic liquid | 石家庄学院 | 2017-02-08 | — | — | CN | claimed |
| CN-119015834-A | Carbon dioxide separation membrane and preparation method thereof | 国家能源投资集团有限责任公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-112955135-B | Composition, sprayer and wiping cloth | 富士胶片株式会社 | 2024-02-09 | — | — | CN | disclosed |
| EP-3886823-A1 | WOVEN, NONWOVEN, COTTON, NONWOVEN-COTTON BLENDED POLYETHYLENE AND POLIPROPILEN AND POLYSTYRENE MASK, WOUND DRESSING, PANTY, BRA, HANDKERCHIEF, PAD, SCOURING PAD, DISPOSABLE SURGICAL DRESS, DISPOSABLE SHEETS WITH ANTIMICROBIAL PROPERTIES | UCAR Health GmbH (DE) | 2021-10-06 | — | — | EP | disclosed |
| CN-112955135-A | Composition, sprayer and wiping cloth | 富士胶片株式会社 | 2021-06-11 | — | — | CN | disclosed |
| EP-3773502-A1 | TREATMENT OF CANCER BY GUANIDINIUM DERIVATIVES | UCAR Health GmbH (DE) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020112039-A1 | WOVEN, NONWOVEN, COTTON, NONWOVEN-COTTON BLENDED POLYETHYLENE AND POLIPROPILEN AND POLYSTYRENE MASK, WOUND DRESSING, PANTY, BRA, HANDKERCHIEF, PAD, SCOURING PAD, DISPOSABLE SURGICAL DRESS, DISPOSABLE SHEETS WITH ANTIMICROBIAL PROPERTIES | DILCEM KIMYA VE DENISMANLIK ITH. IHR. SAN. TIC. LTD. STI. (TR) | 2020-06-04 | — | — | WO | disclosed |
| WO-2019194756-A1 | TREATMENT OF CANCER BY GUANIDINIUM DERIVATIVES | UCAR DILEK (TR) | 2019-10-10 | — | — | WO | disclosed |
| CN-105873982-B | Polyetherimide with improved melt stability | 沙特基础工业全球技术有限公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-1089755-C | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | PHARMACIA & UPJOHN SPA (IT) | 2002-08-28 | — | — | CN | disclosed |
| US-20020028748-A1 | Herbicidal 3 -heterocyclic substituted benzisothiazole and benzisoxazole compounds | INTELLECTUAL PROPERTY DEPARTMENT BASF AKTIENGESELLSCHAFT (DE) | 2002-03-07 | — | — | US | disclosed |
| WO-2001079203-A1 | HERBICIDAL 3-HETEROCYCLIC SUBSTITUTED BENZISOTHIAZOLE AND BENZISOXAZOLE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-25 | — | — | WO | disclosed |
| CN-1226232-A | Acryloyl substituted distamycin derivatives, process for their preparation, and their use as antitumor and antiviral agents | PHARMACIA & UPJOHN SPA (IT) | 1999-08-18 | — | — | CN | disclosed |
| CN-1222144-A | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | PHARMACIA & UPJOHN SPA (IT) | 1999-07-07 | — | — | CN | disclosed |
| EP-0517852-A4 | — | — | 1994-03-02 | — | — | EP | disclosed |
| EP-0517852-A1 | TRI- AND TETRA-SUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON (US) | 1992-12-16 | — | — | EP | disclosed |
| US-5137890-A | Gastrointestinal disorders, antiulcer agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-08-11 | — | — | US | disclosed |
| WO-1991012797-A1 | TRI- AND TETRA-SUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALF SCIENCES UNIVERSITY (US) | 1991-09-05 | — | — | WO | disclosed |